Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy

NCT00957372 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

253

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Epilepsy

Interventions

DRUG: eslicarbazepine acetate
DRUG: placebo (Part I)
DRUG: ESL - Open-label Extension (Part II)

Sponsor

Bial - Portela C S.A.